Significats de solid malignancies en anglès

The majority of patients with solid malignancies die from metastatic burden.

However, they are rare as compared to other solid malignancies.

Pancreatic cancer is one of the most aggressive solid malignancies with a dismal survival rate.

Experimental design: Patients with advanced solid malignancies were premedicated and treated with escalating doses of BMS-247550.

Notch signaling pathway activators and inhibitors are currently in early clinical development for treatment of solid malignancies.

Methods: Patients with advanced solid malignancies received KOS-1584 every 3 weeks until disease progression.

Nonmyeloablative allogeneic transplantation is an emerging therapy for hematologic and solid malignancies and potentially offers patients reduced transplant-related toxicity.

Thrombocytosis is present in more than 30% of patients with solid malignancies and correlates with worsened patient survival.

Thirteen patients with advanced solid malignancies were treated with MKT-077 administered as a 30-min i.v.

This study examined the impact of race and socioeconomic factors on the use of proton therapy in children with solid malignancies.

This approach may facilitate the clinical application of radionuclides with shorter half-lives, such as 211At, for the therapy of solid malignancies.

Evidence has indicated that the presence of CTCs in the peripheral blood of men with solid malignancies correlates with clinical outcomes.

Cisplatin is a highly successful and widely used chemotherapy for the treatment of various solid malignancies in both adult and pediatric patients.

Together, these results demonstrate that ibrutinib modulates MDSC function and generation, revealing a potential strategy for enhancing immune-based therapies in solid malignancies.

It was administered as a 30-min infusion once every 4 weeks to patients with advanced solid malignancies.

However, it is up-regulated in a diverse set of hematologic and solid malignancies, thus ROR2 represents a candidate antigen for antibody-based cancer therapy.